Related Products
FEMARA 2.5 MG 30TAB
Femara ingredients
Femara contains "letrozole", which helps increase estrogen levels by inhibiting the enzyme "aromatase", which reduces the synthesis of strogen, helping to treat estrogen-dependent breast cancer.
Femara uses
Femara 2.5 mg tablets are used for the treatment of estrogen-dependent breast cancer in the blood as follows:
- Adjuvant treatment for early hormone +ve breast cancer postmenopausal.
- extended adjuvant treatment for women with early breast cancer after menopause who have previously received tamoxifen for 5 years.
- A first-line treatment for advanced breast cancer which is hormone dependent.
- Treatment of advanced breast cancer relapse or progression of the disease for women who have artificially induced postmenopausal state, who have previously been treated by anti-estrogens.
- Dosage of Vimara tablets
- The appropriate dose of Vimara's tablets is determined by the doctor.
- The recommended dose per day is a tablet of 2.5 mg once per day.
Femara Side Effects
Femara may cause some side effects, such as:
- Hypercholesterolemia.
- Increase or low appetite.
- Depression.
- headache.
- dizziness.
- palpitations.
- Hot flushes.
- High blood pressure.
- Nausea and vomiting.
- excessive sweating.
- Joint pain.
- vaginal bleeding.
- Weight gain.
Femara contraindications
Femara is not used in the case of:
- Allergy to drug ingredients.
- Pregnancy and lactation.
Femara use precautions
The doctor should be consulted before using the medicine Femara, especially in the case of:
- osteoporosis, as the risk of developing it may increase.
- kidney disease.
- liver disease.
- Uncleraed menopausal status.
Drug interactions
The doctor should be consulted before taking Femarawith any other medication, especially:
- Antifungal.
- Antibiotics.
- Antiepileptic.
- Tamoxifen.
- Anticoagulants.
Translation missing: en.general.search.loading